v3.26.3
Employee Benefits (Tables)
9 Months Ended
Sep. 30, 2026
Employee Benefits  
Schedule of share information held by the ESOP

​

​

​

​

​

​

​

​

​

​

As of

​

​

September 30, 2026

​

December 31, 2025

​

​

(Dollars in thousands)

Allocated shares

​

​

341,646

​

​

170,823

Shares committed to be released

​

​

127,766

​

​

170,823

Unallocated shares

​

​

2,947,046

​

​

3,074,812

Total shares

​

​

3,416,458

​

​

3,416,458

Fair value of unallocated shares

​

$

65,189

​

$

60,943

Schedule of restricted stock award activities

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 2026

​

Three Months Ended September 30, 2025

​

​

Number of Shares

​

Weighted-Average Grant Date Fair Value Per Share

​

Number of Shares

​

Weighted-Average Grant Date Fair Value Per Share

​

​

​

​

​

​

​

​

​

Non-vested balance at beginning of period

​

1,283,224

$

17.57

​

1,284,525

$

16.41

Granted

​

—

​

—

​

—

​

—

Vested

​

—

​

—

​

—

​

—

Cancelled (1)

​

—

​

—

​

—

​

—

Non-vested balance at end of period

​

1,283,224

$

17.57

​

1,284,525

$

16.41

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 2026

​

Nine Months Ended September 30, 2025

​

​

Number of Shares

​

Weighted-Average Grant Date Fair Value Per Share

​

Number of Shares

​

Weighted-Average Grant Date Fair Value Per Share

​

​

​

​

​

​

​

​

​

Non-vested balance at beginning of period

​

1,284,525

$

16.41

​

—

$

—

Granted

​

283,559

​

21.64

​

1,284,525

​

16.41

Vested

​

(256,899)

​

16.41

​

—

​

—

Cancelled (1)

​

(27,961)

​

16.41

​

—

​

—

Non-vested balance at end of period

​

1,283,224

$

17.57

​

1,284,525

$

16.41

​

(1)Represents restricted stock awards (“RSAs”) cancelled upon vesting for employee payroll tax withholding and upon forfeiture.
Schedule of compensation expense and income tax benefits recognized for restricted stock awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Nine Months Ended

​

Three Months Ended

​

Nine Months Ended

​

​

September 30, 2026

​

September 30, 2025

​

​

(in thousands)

Stock-based compensation expense:

​

​

​

​

​

​

​

​

​

​

​

​

Restricted stock awards

​

$

1,737

​

$

4,917

​

$

1,061

​

$

1,848

Total stock-based compensation expense

​

$

1,737

​

$

4,917

​

$

1,061

​

$

1,848

Related tax benefits recognized in earnings

​

$

47

​

$

140

​

$

—

​

$

—